Select Publications

 

Dichotomous Effects of Cellular Expression of STAT3 on Tumor Growth of HNSCCBickett TE, Knitz MW, Piper M, Oweida AJ, Gadwa J, Darragh LB, Nguyen D, Bhatia S, Bhuvane S, Phan AV, Van Court B, Corbo S, Pham T, Dent AL, Lenz L, Karam SD. Mol Ther. 2021 Nov 15:S1525-0016(21)00582-7. doi: 10.1016/j.ymthe.2021.11.011. Epub ahead of print. PMID: 34793974.

Amateur antigen-presenting cells in the tumor microenvironmentDarragh LB, Karam SDMol Carcinog. 2021 Sep 27. doi: 10.1002/mc.23354. PMID: 34570920.

Loss of cancer cell STAT1 improves response to radiation therapy and promotes T cell activation in head and neck squamous cell carcinoma. Knitz MW, Darragh LB, Bickett TE, Bhatia S, Bukkapatnam S, Gadwa J, Piper M, Corbo S, Nguyen D, Van Court B, Oweida A, Karam SD. Cancer Immunol Immunother. 2021 Sep 24. doi: 10.1007/s00262-021-03059-3. PMID: 34559306.

FLT3L Release by Natural Killer Cells Enhances Response to Radioimmunotherapy in Preclinical Models of HNSCCBickett TE, Knitz M, Darragh LB, Bhatia S, Van Court B, Gadwa J, Bhuvane S, Piper M, Nguyen D, Tu H, Lenz L, Clambey ET, Barry K, Karam SD. Clin Cancer Res. 2021 Sep 13. doi: 10.1158/1078-0432.CCR-21-0971. PMID: 34518311.

Targeting resistance to radiation-immunotherapy in cold HNSCCs by modulating the Treg-dendritic cell axisKnitz MW, Bickett TE, Darragh LB, Oweida AJ, Bhatia S, Van Court B, Bhuvane S, Piper M, Gadwa J, Mueller AC, Nguyen D, Nangia V, Osborne DG, Bai X, Ferrara SE, Boss MK, Goodspeed A, Burchill MA, Tamburini BAJ, Chan ED, Pickering CR, Clambey ET, Karam SD. J Immunother Cancer. 2021 Apr;9(4):e001955. doi: 10.1136/jitc-2020-001955. PMID: 33883256; PMCID: PMC8061827.

Complement C3a and C5a receptor blockade modulates regulatory T cell conversion in head and neck cancerGadwa J, Bickett TE, Darragh LB, Knitz MW, Bhatia S, Piper M, Van Court B, Bhuvane S, Nguyen D, Nangia V, Kleczko EK, Nemenoff RA, Karam SD. J Immunother Cancer. 2021 Mar;9(3):e002585. doi: 10.1136/jitc-2021-002585. PMID: 33789881.

Induction of ADAM10 by RT drives fibrosis, resistance, and EMT in pancreatic cancerMueller AC, Piper M, Goodspeed A, Bhuvane S, Williams JS, Bhatia S, Phan AV, Van Court B, Zolman KL, Peña B, Oweida AJ, Zakem S, Meguid C, Knitz MW, Darragh L, Bickett TE, Gadwa J, Mestroni L, Taylor MRG, Jordan KR, Dempsey P, Lucia MS, McCarter MD, Del Chiaro M, Messersmith WA, Schulick RD, Goodman KA, Gough MJ, Greene CS, Costello JC, Galvao Neto A, Lagares D, Hansen KC, Van Bokhoven A, Karam SD. Cancer Res. 2021 Feb 1:canres.CAN-20-3892-A.2020. doi: 10.1158/0008-5472.CAN-20-3892. Epub ahead of print. PMID: 33526513.

Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotideOweida AJ, Mueller AC, Piper M, Milner D, Van Court B, Bhatia S, Phan A, Bickett T, Jordan K, Proia T, Schulick R, Messersmith WA, Del Chiaro M, Clambey E, Gough MJ, Williams J, Hansen K, Goodman K, Karam SD. Cancer Immunol Immunother. 2020 Oct 23. doi: 10.1007/s00262-020-02701-w. Epub ahead of print. PMID: 33097963.

Tuberculosis-Cancer Parallels in Immune Response RegulationBickett TE, Karam SD. Int J Mol Sci. 2020 Aug 26;21(17):6136. doi: 10.3390/ijms21176136. PMID: 32858811; PMCID: PMC7503600.

Deciphering the Intricate Roles of Radiation Therapy and Complement Activation in Cancer. Gadwa J, Karam SDInt J Radiat Oncol Biol Phys. 2020 Jul 3:S0360-3016(20)31366-3. doi: 10.1016/j.ijrobp.2020.06.067. PMID: 32629082.

The effects of ephrinB2 signaling on proliferation and invasion in glioblastoma multiforme. Bhatia S, Bukkapatnam S, Van Court B, Phan A, Oweida A, Gadwa J, Mueller AC, Piper M, Darragh L, Nguyen D, Gilani A, Knitz M, Bickett T, Green A, Venkataraman S, Vibhakar R, Cittelly D, Karam SDMol Carcinog. 2020 Jun 22. doi: 10.1002/mc.23237. Epub ahead of print. PMID: 32567728.

The interplay between cancer associated fibroblasts and immune cells in the context of radiation therapyPiper M, Mueller AC, Karam SD. Mol Carcinog. 2020 Jul;59(7):754-765. doi: 10.1002/mc.23205. Epub 2020 May 4. PMID: 32363633.

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response AssessmentOweida AJ, Bhatia S, Van Court B, Darragh L, Serkova N, Karam SD. J Vis Exp. 2019 Apr 22;(146):10.3791/59195. doi: 10.3791/59195. PMID: 31058896; PMCID: PMC6659716.

Pancreatic Tumor Microenvironment Modulation by EphB4-ephrinB2 Inhibition and Radiation CombinationLennon S, Oweida A, Milner D, Phan AV, Bhatia S, Van Court B, Darragh L, Mueller AC, Raben D, Martínez-Torrecuadrada JL, Pitts TM, Somerset H, Jordan KR, Hansen KC, Williams J, Messersmith WA, Schulick RD, Owens P, Goodman KA, Karam SD. Clin Cancer Res. 2019 Jun 1;25(11):3352-3365. doi: 10.1158/1078-0432.CCR-18-2811. Epub 2019 Apr 3. PMID: 30944125; PMCID: PMC6548606.

Inhibition of EphB4-Ephrin-B2 Signaling Reprograms the Tumor Immune Microenvironment in Head and Neck CancersBhatia S, Oweida A, Lennon S, Darragh LB, Milner D, Phan AV, Mueller AC, Van Court B, Raben D, Serkova NJ, Wang XJ, Jimeno A, Clambey ET, Pasquale EB, Karam SD. Cancer Res. 2019 May 15;79(10):2722-2735. doi: 10.1158/0008-5472.CAN-18-3257. Epub 2019 Mar 20. PMID: 30894369; PMCID: PMC6522285.

Oweida AJ, Darragh L, Phan A, Binder D, Bhatia S, Mueller A, Court BV, Milner D, Raben D, Woessner R, Heasley L, Nemenoff R, Clambey E, Karam SD. STAT3 Modulation of Regulatory T Cells in Response to Radiation Therapy in Head and Neck Cancer. J Natl Cancer Inst. 2019 Dec 1;111(12):1339-1349. doi: 10.1093/jnci/djz036. PMID: 30863843; PMCID: PMC6910208.

Overcoming Resistance to Combination Radiation-Immunotherapy: A Focus on Contributing Pathways Within the Tumor MicroenvironmentDarragh LB, Oweida AJ, Karam SD. Front Immunol. 2019 Jan 31;9:3154. doi: 10.3389/fimmu.2018.03154. PMID: 30766539; PMCID: PMC6366147.

Resistance to Radiotherapy and PD-L1 Blockade Is Mediated by TIM-3 Upregulation and Regulatory T-Cell InfiltrationOweida A, Hararah MK, Phan A, Binder D, Bhatia S, Lennon S, Bukkapatnam S, Van Court B, Uyanga N, Darragh L, Kim HM, Raben D, Tan AC, Heasley L, Clambey E, Nemenoff R, Karam SD. Clin Cancer Res. 2018 Nov 1;24(21):5368-5380. doi: 10.1158/1078-0432.CCR-18-1038. Epub 2018 Jul 24. PMID: 30042205; PMCID: PMC6886391.

Role of EphB3 Receptor in Mediating Head and Neck Tumor Growth, Cell Migration, and Response to PI3K InhibitorBhatia S, Griego A, Lennon S, Oweida A, Sharma J, Rohmer C, Uyanga N, Bukkapatnam S, Van Court B, Raben D, Young C, Heasley L, Karam SD. Mol Cancer Ther. 2018 Sep;17(9):2049-2059. doi: 10.1158/1535-7163.MCT-17-1163. Epub 2018 Jul 3. PMID: 29970482; PMCID: PMC6238629.

Inhibition of EphB4-Ephrin-B2 Signaling Enhances Response to Cetuximab-Radiation Therapy in Head and Neck CancersBhatia S, Sharma J, Bukkapatnam S, Oweida A, Lennon S, Phan A, Milner D, Uyanga N, Jimeno A, Raben D, Somerset H, Heasley L, Karam SD. Clin Cancer Res. 2018 Sep 15;24(18):4539-4550. doi: 10.1158/1078-0432.CCR-18-0327. Epub 2018 May 30. PMID: 29848571; PMCID: PMC6886390.

Ionizing radiation sensitizes tumors to PD-L1 immune checkpoint blockade in orthotopic murine head and neck squamous cell carcinomaOweida A, Lennon S, Calame D, Korpela S, Bhatia S, Sharma J, Graham C, Binder D, Serkova N, Raben D, Heasley L, Clambey E, Nemenoff R, Karam SD. Oncoimmunology. 2017 Aug 3;6(10):e1356153. doi: 10.1080/2162402X.2017.1356153. PMID: 29123967; PMCID: PMC5665079.

Combined EphB2 receptor knockdown with radiation decreases cell viability and invasion in medulloblastomaBhatia S, Hirsch K, Sharma J, Oweida A, Griego A, Keysar S, Jimeno A, Raben D, Krasnoperov V, Gill PS, Pasquale EB, Wang XJ, Karam SD.  Cancer Cell Int. 2017 Mar 29;17:41. doi: 10.1186/s12935-017-0409-7. PMID: 28360821; PMCID: PMC5371267.

Enhancing radiosensitization in EphB4 receptor-expressing Head and Neck Squamous Cell CarcinomasBhatia S, Hirsch K, Sharma J, Oweida A, Griego A, Keysar S, Jimeno A, Raben D, Krasnoperov V, Gill PS, Pasquale EB, Wang XJ, Karam SD. Sci Rep. 2016 Dec 12;6:38792. doi: 10.1038/srep38792. PMID: 27941840; PMCID: PMC5150255.

Ephrin-B2 overexpression predicts for poor prognosis and response to therapy in solid tumorsOweida A, Bhatia S, Hirsch K, Calame D, Griego A, Keysar S, Pitts T, Sharma J, Eckhardt G, Jimeno A, Wang XJ, Parkash G, Califano J, Karam SD. Mol Carcinog. 2017 Mar;56(3):1189-1196. doi: 10.1002/mc.22574. Epub 2016 Nov 1. PMID: 27649287; PMCID: PMC5939940.

Effects of altered ephrin-A5 and EphA4/EphA7 expression on tumor growth in a medulloblastoma mouse modelBhatia S, Hirsch K, Baig NA, Rodriguez O, Timofeeva O, Kavanagh K, Lee YC, Wang XJ, Albanese C, Karam SD. J Hematol Oncol. 2015 Sep 7;8:105. doi: 10.1186/s13045-015-0202-9. PMID: 26345456; PMCID: PMC4561476.

Knockdown of EphB1 receptor decreases medulloblastoma cell growth and migration and increases cellular radiosensitization. Bhatia S, Baig NA, Timofeeva O, Pasquale EB, Hirsch K, MacDonald TJ, Dritschilo A, Lee YC, Henkemeyer M, Rood B, Jung M, Wang XJ, Kool M, Rodriguez O, Albanese C, Karam SD.Oncotarget. 2015 Apr 20;6(11):8929-46. doi: 10.18632/oncotarget.3369. PMID: 25879388; PMCID: PMC4496193.